Aviva
PRNB

Aviva’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Aviva’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,581
Closed -$2.43M – 962
2020
Q2 		$2.43M Sell
40,581
-28,200
-41% -$1.74M 0.02% 580
2020
Q1 		$4.08M Buy
+68,781
New +$4.01M 0.03% 454

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Aviva's PRNB Position: Q3 2020 in Review

Aviva sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 40,581 shares — an estimated $2.43M sold.

Aviva first reported a position in PRNB in Q1 2020 and held it in 2 quarters. The position peaked at $4.08M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Aviva reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Aviva sold 40,581 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.43M.
  • Aviva first reported a position in Principia Biopharma Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Aviva's Principia Biopharma Inc. Common Stock position peaked at $4.08M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Aviva's 13F filing for Q3 2020, filed 12 Nov 2020.